1-26161881-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024869.3(FAM110D):c.590C>G(p.Ala197Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000207 in 1,469,266 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A197D) has been classified as Uncertain significance.
Frequency
Consequence
NM_024869.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000148 AC: 11AN: 74144Hom.: 0 AF XY: 0.0000946 AC XY: 4AN XY: 42268
GnomAD4 exome AF: 0.000210 AC: 277AN: 1317100Hom.: 0 Cov.: 32 AF XY: 0.000221 AC XY: 143AN XY: 645710
GnomAD4 genome AF: 0.000177 AC: 27AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.590C>G (p.A197G) alteration is located in exon 2 (coding exon 1) of the FAM110D gene. This alteration results from a C to G substitution at nucleotide position 590, causing the alanine (A) at amino acid position 197 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at